Skip to main content
. 2020 Apr 24;11:505. doi: 10.3389/fphar.2020.00505

Figure 1.

Figure 1

Total drug plasma concentration of VRC from 193 patients with malignant hematologic disease in day 1, 4, 7, 10, 14 (n=240, 230, 214,142, 106 respectively). Ct, total drug concentration; Cmin, trough plasma concentration; Cmax, peak plasma concentration. All patients were administered by intravenous drip (2 hours), 4 mg/kg (twice a day) after a loading dose of 6 mg/kg (every 12 h) in day 1. Both the Cmin and the Cmax of VRC reached the steady state from day 4.